Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Zydus Lifesciences LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532321NSE Symbol: ZYDUSLIFEP/E(TTM):18.37
ISIN Demat:INE010B01027Div & Yield %:1.25EPS(TTM):47.96
Book Value(Rs):215.0764496Market Cap ( Cr.):88659.28Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 15116.3010818.708731.607836.907780.006347.40
Excise Duty0.000.000.000.000.000.00
Net Sales15116.3010818.708731.607836.907780.006347.40
Other Income 696.201084.80548.40178.7089.30908.70
Stock Adjustments 121.10131.70-105.1046.90148.30-15.50
Total Income15933.6012035.209174.908062.508017.607240.60
EXPENDITURE :      
Raw Materials 3138.003284.603066.202917.102499.701936.20
Power & Fuel Cost286.20298.20278.60245.20193.20208.40
Employee Cost 1762.201507.501321.901204.901147.301077.40
Other Manufacturing Expenses 439.70347.20332.50381.10363.40327.30
Selling and Administration Expenses 1384.001017.801039.80958.401009.10925.30
Miscellaneous Expenses 491.00445.00336.90578.30594.40486.20
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure7501.106900.306375.906285.005807.104960.80
Operating Profit8432.505134.902799.001777.502210.502279.80
Interest 463.90390.70278.20134.9070.90233.90
Gross Profit7968.604744.202520.801642.602139.602045.90
Depreciation523.90504.40488.60478.70451.10428.90
Profit Before Tax7444.704239.802032.201163.901688.501617.00
Tax1582.50934.30461.80260.20303.30164.10
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax87.30-136.0041.2045.80-91.0040.00
Reported Net Profit5774.903441.501529.20857.901476.201412.90
Extraordinary Items 27.403.90-92.27-237.64-156.95-52.67
Adjusted Net Profit5747.503437.601621.471095.541633.151465.57
Adjst. below Net Profit -26.40-54.001.80-6.90-15.30-6.00
P & L Balance brought forward13347.6010567.409289.408796.907336.006645.70
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 301.90607.30253.00358.500.00716.60
P & L Balance carried down18794.2013347.6010567.409289.408796.907336.00
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1100.00300.00600.00250.00350.00350.00
Earnings Per Share-Unit Curr57.4034.2115.118.3814.4213.80
Earnings Per Share(Adj)-Unit Curr57.4034.2115.118.3814.4213.80
Book Value-Unit Curr210.64156.23134.78129.30124.46109.96